Dr. Agarwal's Healthcare IPO Day 1: Check GMP, Subscription Status & Key Highlights
Dr. Agarwal Healthcare is a known healthcare provider of eye care services, along with consultations, diagnostic services and non-surgical treatments. Founded in 2010, the company also offers optical products, accessories and eye care-related pharmaceuticals. Dr. Agarwal Healthcare IPO opens for subscription on January 29, 2025, and closes on January 31, 2025.
Dr. Agarwal’s Healthcare IPO Details
Dr. Agarwal’s Healthcare IPO opens for subscription on January 29, 2025, and closes on January 31, 2025. The offering includes a fresh issue of shares worth ₹300 crore and an offer for sale (OFS) of existing shares worth ₹2,727.26 crore. The price band is set at ₹382 to ₹402 per share. The shares are expected to be listed on the BSE and NSE on February 5, 2025. The IPO is managed by Kotak Mahindra Capital, Morgan Stanley India, Jefferies India, and Motilal Oswal Investment Advisors, with Kfin Technologies as the registrar. The basis of allotment will be finalized on February 3, 2025, followed by the initiation of refunds on February 4, 2025.
Dr. Agarwal’s Healthcare IPO Day 1 Subscription Status
(January 29, 2025, 11:09:52 AM, Day 1)
By January 29, 2025, Dr. Agarwal’s Healthcare IPO was subscribed 0.02 times as of 10:40 a.m. on Wednesday, Jan 29, 2025, as per the BSE data. The retail investor category led with a subscription of 0.03 times, while Qualified Institutional Buyers (QIB) subscribed 0 times, and Non-Institutional Investors (NII) saw a subscription of 0.05 times.
Utilisation of Proceeds
The company proposes to utilise the net proceeds from the fresh issue towards funding of the following objects:
- Repayment/prepayment, in part or full, of certain of our borrowings and
- General corporate purposes and unidentified inorganic acquisition
GMP Details
According to NDTV Profit, as of January 29, 2025, at 8:30 AM, the latest GMP for Dr Agarwal’s Healthcare IPO stands at ₹12, indicating a 3% premium to the upper price band. As per the latest GMP trends, the estimated listing price is projected to be Rs 414.
Dr. Agarwal’s Healthcare Business Overview
Dr. Agarwal's Health Care is a healthcare provider focused on advanced eye care services, operating under the brand Dr. Agarwal’s Eye Institute. The company offers a range of services, including routine eye check-ups, cataract surgeries, LASIK procedures, retina treatments, and corneal transplants. As of September 2024, the company has a network of 209 facilities, including 16 in Africa and 193 in India, making it the largest among its peers. The company also emphasizes research and development in ophthalmology. In FY24, Dr Agarwal's Healthcare served 2.13 million patients and performed over 220,000 surgeries.
Disclaimer: The GMP (Grey Market Premium) price is unauthenticated market-related news and has no discernible basis. The same quoted above is as per news that appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade or deal in the grey market nor do we recommend or endorse trading in the grey market.